10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
B-Cell Lymphomas
3 articles
New Hope for BTK Inhibitor Intolerant Patients: Pirtobrutinib Shows Promise in B-Cell Malignancies
Pirtobrutinib demonstrates efficacy and tolerability in patients with B-cell cancers who couldn't tolerate other BTKis.
Long-Term Study Challenges Rituximab Maintenance in Low-Burden Follicular Lymphoma
Extended follow-up of RESORT trial shows rituximab retreatment may be preferable to maintenance therapy.
Acyclovir Prophylaxis Slashes Mucositis Risk in Stem Cell Transplant Patients
Study shows acyclovir prophylaxis significantly reduces oral mucositis in autologous stem cell transplants.